Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1146219 | 0.79 | TSHR (0.38) | ALOX15TSHRKDM4EACMSDTDP1 | |
| Hydrochloric Acid SCHEMBL2032392 | 0.76 | TSHR (0.36) | ALOX15TSHRKDM4EACMSDTDP1 | |
| Potassium SCHEMBL30932480 | 0.76 | TSHR (0.36) | ALOX15TSHRKDM4EACMSDTDP1 | |
| SCHEMBL29223372 | 0.76 | TSHR (0.36) | ALOX15TSHRKDM4EACMSDTDP1 | |
| SCHEMBL11322870 | 0.73 | — | — | |
| SCHEMBL8109492 | 0.71 | KMO (0.35) | ALOX15TSHRKDM4EACMSDTDP1 | |
| SCHEMBL944176 | 0.71 | ALOX15 (0.39) | ALOX15TSHRKDM4EACMSDTDP1 | |
| Urea SCHEMBL400230 | 0.69 | LMNA (0.46) | ALOX15TDP1 | |
| SCHEMBL7696671 | 0.67 | KMO (0.32) | ALOX15TSHRKDM4EACMSDTDP1 | |
| SCHEMBL7692962 | 0.67 | TSHR (0.47) | ALOX15TSHRKDM4EACMSDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1294682-A | Compsn. and method for hemoglobin and cell analysis | COULTER INT CORP (US) | 2001-05-09 | — | — | CN | claimed |
| CN-1244259-A | A cyanide-free lytic reagent compositiona nd method for hemoglobin and cell analysis | COULTER INT CORP (US) | 2000-02-09 | — | — | CN | claimed |
| US-10266737-B2 | Adsorption systems using metal-organic frameworks | ARKEMA INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-20150291870-A1 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | ARKEMA INC. | 2015-10-15 | — | — | US | disclosed |
| EP-2885365-A2 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | Arkema, Inc. (US) | 2015-06-24 | — | — | EP | disclosed |
| WO-2014028574-A9 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | ARKEMA INC. (US) | 2015-04-02 | — | — | WO | disclosed |
| WO-2014028574-A2 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | ARKEMA INC. (US) | 2014-02-20 | — | — | WO | disclosed |
| CN-102662067-A | Cyanide-free hemolysin for determining hemoglobin concentration and carrying out white blood cell count by groups | YANTAI EXCELLENT BIOTECHNOLOGY CO LTD | 2012-09-12 | — | — | CN | disclosed |
| WO-2009083553-A1 | AZINE COMPOUNDS AS GLUCOKINASE ACTIVATORS | RHEOSCIENCE A/S (DK) | 2009-07-09 | — | — | WO | disclosed |
| CN-1154848-C | A cyanide-free lytic reagent compositiona nd method for hemoglobin and cell analysis | ���ع��ʹ�˾ | 2004-06-23 | — | — | CN | disclosed |
| CN-1153972-C | Compsn. and method for hemoglobin and cell analysis | 库特国际公司 | 2004-06-16 | — | — | CN | disclosed |
| US-6337368-B1 | WATER INSOLUBLE CARRIERS WITH P-NITROBENZOIC ACID, AROMATIC AMINES, AMIDES, SULFONAMIDES AND HYDRAZIDES | KANEKA CORPORATION (JP) | 2002-01-08 | — | — | US | disclosed |
| CN-1294682-A | Compsn. and method for hemoglobin and cell analysis | COULTER INT CORP (US) | 2001-05-09 | — | — | CN | disclosed |
| CN-1244259-A | A cyanide-free lytic reagent compositiona nd method for hemoglobin and cell analysis | COULTER INT CORP (US) | 2000-02-09 | — | — | CN | disclosed |
| EP-0003817-B1 | ANTI-CORROSIVE PAINTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-4213986-A | DERIVATIVES CONTAIN TETRAZOLE RING, TREATMENT OF PURINE METABOLIC DISORDER, ANTIURICOPATHIC | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-07-22 | — | — | US | disclosed |
| US-4152440-A | DIURETICS, ANALGESICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291870-A1 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | PFAS, CHIA, PARN | ALOX15 2929/4885TSHR 4470/4885KDM4E 1450/4885 |
| US-10266737-B2 | Adsorption systems using metal-organic frameworks | PFAS, CHIA, PARN | ALOX15 2929/4885TSHR 4470/4885KDM4E 1450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.